Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Change in Acquisitions & Divestments (2020 - 2023)

Cullinan Therapeutics has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $117.5 million for Q4 2023.

  • Quarterly results put Change in Acquisitions & Divestments at $117.5 million for Q4 2023, down 11.4% from a year ago — trailing twelve months through Dec 2023 was $409.4 million (up 16.0% YoY), and the annual figure for FY2025 was $416.6 million, down 28.77%.
  • Change in Acquisitions & Divestments for Q4 2023 was $117.5 million at Cullinan Therapeutics, up from $93.8 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CGEM hit a ceiling of $132.6 million in Q4 2022 and a floor of $4.2 million in Q1 2020.
  • Median Change in Acquisitions & Divestments over the past 4 years was $61.4 million (2021), compared with a mean of $63.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 662.08% in 2022 and later decreased 11.4% in 2023.
  • Cullinan Therapeutics' Change in Acquisitions & Divestments stood at $32.9 million in 2020, then skyrocketed by 86.41% to $61.4 million in 2021, then surged by 115.96% to $132.6 million in 2022, then fell by 11.4% to $117.5 million in 2023.
  • The last three reported values for Change in Acquisitions & Divestments were $117.5 million (Q4 2023), $93.8 million (Q3 2023), and $93.6 million (Q2 2023) per Business Quant data.